Cover Image
市場調查報告書

凝血酶的中國市場

Investigation Report on China Thrombin Market, 2010-2019

出版商 China Research and Intelligence 商品編碼 333640
出版日期 內容資訊 英文 35 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
凝血酶的中國市場 Investigation Report on China Thrombin Market, 2010-2019
出版日期: 2015年06月25日 內容資訊: 英文 35 Pages
簡介

中國的凝血酶的銷售額從2005年到2014年以約5.6%的年複合成長率發展,從2005年的1300萬人民幣,成長到2014年的2077萬人民幣的規模。由於生活方式的變化和高齡化,國內的心血管系統疾病的發病率的持續增加等,該市場預計這次也將更為擴大。

本報告提供中國的凝血酶市場相關調查、凝血酶的功效與效果、中國市場中專利及核准狀況、銷售額&銷售量的變化與預測、價格趨勢、主要製造商與市場佔有率、競爭環境與其展望、主要製造商簡介等彙整資料。

第1章 凝血酶的相關概念

  • 功效、效果
  • 全球市場銷售情形

第2章 中國的凝血酶的市場簡介

  • 專利、核準情況
  • 主要製造商
  • 市場規模

第3章 中國的凝血酶銷售情形

  • 銷售額
  • 銷售量

第4章 中國的凝血酶主要廠商的市場佔有率

  • 市場佔有率:銷售額
  • 市場佔有率:銷售量

第5章 中國的凝血酶的各劑型佔有率

  • 各種劑型的市場佔有率:銷售額
  • 各種劑型的市場佔有率:銷售量

第6章 中國的醫院的凝血酶參照價格

  • Shanghai Livzon Pharmaceutical Co., Ltd
  • Shanghai No.1 Biochemical & Pharmaceutical Co., Ltd
  • Nanjing Xinbai Pharmaceuitcal Co., Ltd
  • Wuxi Kaifu Pharmaceutical Co., Ltd (商品名:Kaitian)
  • Hacon Pharma
  • Wuhan Hiteck Biological Pharma Co., Ltd
  • Hunan Yige Pharmaceutical Co., Ltd
  • Biochemical Pharmaceutical Factory of Zhuhai S. E. Z.
  • Changchun Guoao Pharmaceutical Co., Ltd (商品名:Bangting)

第7章 中國市場中凝血酶主要製造商

  • Changchun Guoao Pharmaceutical Co., Ltd
  • Biochemical Pharmaceutical Factory of Zhuhai S. E. Z.
  • Hunan Yige Pharmaceutical Co., Ltd
  • Hacon Pharma
  • Wuxi Kaifu Pharmaceutical Co., Ltd

第8章 中國的凝血酶市場展望

  • 市場規模預測
  • 競爭情形的預測

圖表

目錄
Product Code: 1506245

Anticoagulant, including various products, is mainly used to prevent blood clotting. It will also be used when patients need to connect to some medical instruments or receive blood transfusions or when their blood needs to be sent for testing. Through the use of anticoagulant, diseases caused by blood clots like deep venous thrombosis, pulmonary embolism, myocardial infarction and stroke can be avoided.

With the ageing population and the increased incidence of cardiovascular diseases, current gold standard anticoagulants have become unable to satisfy the treatment demand. It is inevitable for improved drugs to come into the market. Warfarin and heparin which have monopolized the anticoagulant market for over half a century will gradually be replaced by the new generation of direct thrombin inhibitor and Xa factor inhibitor and finally fade out.

The representative varieties of thrombin are as follows: hirudin, recombinant hirudin, bivalirudin, argatroban and dabigatran etexilate. Direct thrombin inhibitor brought in a sales value of USD 2.4 billion in 2013, ranking third among anti-clotting drugs. And it occupied 10.4% of the total sales value of anti-clotting drugs while dabigatran etexilate accounted for 73.6% of the sum. According to CRI's survey, the sales value of thrombin in China rose from CNY 13 million in 2005 to CNY 20.77 million in 2014 with CAGR during this period reaching about 5.6%. Currently, major manufacturers of thrombin in the Chinese market are Changchun Guoao Pharmaceutical Co., Ltd, Biochemical Pharmaceutical Factory of Zhuhai S. E. Z., Hunan Yige Pharmaceutical Co., Ltd, Hacon Pharma and Wuxi Kaifu Pharmaceutical Co., Ltd.

With the change of life styles and ageing population, the incidence of cardiovascular disease is expected to keep increasing in the next few years in China, driving the market size of thrombin to expand further.

Readers can get at least the following information from this report:

  • market size of thrombin in China
  • competitive landscape of thrombin in Chinese market
  • price of thrombin made by different enterprises in China
  • market outlook of thrombin in China

The author suggests the following groups of people purchase this report:

  • manufacturers of anticoagulants
  • investors/ research institutions interested in Chinese medicine market
  • any interest in the Chinese medicine market, please contact CRI for customized survey service

Table of Contents

1. Related Concepts of Thrombin

  • 1.1. Indication
  • 1.2. Sales Status in Global Market

2. Market Profile of Thrombin in China

  • 2.1. Patent and Approval Status of Thrombin in China
  • 2.2. Major Manufacturers
  • 2.3. Market Size

3. Survey on Sales Status of Thrombin in China, 2010-2014

  • 3.1. Sales Value
    • 3.1.1. Overall Sales Value
    • 3.1.2. Sales Value by Regions
  • 3.2. Sales Volume
    • 3.2.1. Overall Sales Volume
    • 3.2.2. Sales Volume by Regions

4. Survey on Market Share of Major Manufacturers of Thrombin in China, 2010-2014

  • 4.1. Market Share by Sales Value
  • 4.2. Market Share by Sales Volume

5. Survey on Dosage Forms of Thrombin in China, 2010-2014

  • 5.1. Share of Different Dosage Forms by Sales Value
  • 5.2. Share of Different Dosage Forms by Sales Volume

6. Reference Price of Thrombin in Chinese Hospitals in 2014

  • 6.1. Shanghai Livzon Pharmaceutical Co., Ltd
  • 6.2. Shanghai No.1 Biochemical & Pharmaceutical Co., Ltd
  • 6.3. Nanjing Xinbai Pharmaceuitcal Co., Ltd
  • 6.4. Wuxi Kaifu Pharmaceutical Co., Ltd (Trade Name: Kaitian)
  • 6.5. Hacon Pharma
  • 6.6. Wuhan Hiteck Biological Pharma Co., Ltd
  • 6.7. Hunan Yige Pharmaceutical Co., Ltd
  • 6.8. Biochemical Pharmaceutical Factory of Zhuhai S. E. Z.
  • 6.9. Changchun Guoao Pharmaceutical Co., Ltd (Trade Name: Bangting)

7. Major Manufacturers of Thrombin in Chinese Market, 2010-2014

  • 7.1. Changchun Guoao Pharmaceutical Co., Ltd
  • 7.2. Biochemical Pharmaceutical Factory of Zhuhai S. E. Z.
  • 7.3. Hunan Yige Pharmaceutical Co., Ltd
  • 7.4. Hacon Pharma
  • 7.5. Wuxi Kaifu Pharmaceutical Co., Ltd

8. Market Outlook of Thrombin in China, 2015-2019

  • 8.1. Forecast of Market Size
  • 8.2. Forecast of Competitive Landscape

Table of Selected Charts

  • Chart Approval Information of Thrombin in China
  • Chart Sales Status of Thrombin in China, 2010-2014
  • Chart Sales Value of Thrombin in China, 2010-2014
  • Chart Sales Value of Thrombin in Some Regions in China, 2010-2014
  • Chart Sales Volume of Thrombin in China, 2010-2014
  • Chart Market Share of TOP5 Manufacturers of Thrombin for Sales Value in China, 2010-2014
  • Chart Sales Value and Market Share of Thrombin Made by Changchun Guoao, 2010-2014
  • Chart Sales Value and Market Share of Thrombin Made by Hacon in China, 2010-2014
  • Chart Sales Value and Market Share of Thrombin Made by Hunan Yige in China, 2010-2014
  • Chart Sales Value and Market Share of Thrombin Made by Biochemical Pharmaceutical Factory of Zhuhai S. E. Z. in China, 2010-2014
  • Chart Sales Value and Market Share of Thrombin Made by Wuxi Kaifu Pharmaceutical in China, 2010-2014
  • Chart Price of Thrombin Made by Shanghai Livzon Pharmaceutical Co., Ltd in Some Chinese Cities in 2014
  • Chart Price of Thrombin Made by Shanghai No.1 Biochemical & Pharmaceutical Co., Ltd in Some Chinese Cities in 2014
  • Chart Price of Thrombin Made by Nanjing Xinbai Pharmaceuitcal Co., Ltd in Some Chinese Cities in 2014
  • Chart Price of Thrombin Made by Wuxi Kaifu Pharmaceutical Co., Ltd in Some Chinese Cities in 2014
  • Chart Price of Thrombin Made by Hacon Pharma in Some Chinese Cities in 2014
  • Chart Price of Thrombin Made by Wuhan Hiteck Biological Pharma Co., Ltd in Some Chinese Cities in 2014
  • Chart Price of Thrombin Made by Hunan Yige Pharmaceutical Co., Ltd in Some Chinese Cities in 2014
  • Chart Price of Thrombin Made by Biochemical Pharmaceutical Factory of Zhuhai S. E. Z. in Some Chinese Cities in 2014
  • Chart Price of Thrombin Made by Changchun Guoao Pharmaceutical Co., Ltd in Some Chinese Cities in 2014
Back to Top